Factors influencing patient and health care delays in Oropharyngeal Cancer
- PMID: 32326977
- PMCID: PMC7181590
- DOI: 10.1186/s40463-020-00413-w
Factors influencing patient and health care delays in Oropharyngeal Cancer
Abstract
Background: The incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is increasing. Patients with HPV-associated and HPV-unassociated OPSCC differ in many aspects, which may also impact their diagnostic and management timelines. This study aims at studying the patient, primary health care (PHC) and specialist-care (SC) delays and possible differences between these two patient groups in seeking medical care.
Methods: We reviewed all new patients with OPSCC treated between 2016 and 2018 at our institute, which covers a referral area of 1.6 million people. We collected data on patients' symptoms and factors influencing why they sought medical care using a patient-reported questionnaire and hospital records. We compared delays based on patient and tumor characteristics.
Results: In our study population of 83 patients, the median patient delay was 30 days (range, 0-366), with a median PHC delay of 15 days (range, 0 days-2.5 years), and a median SC delay of 54 days (range, 12-231). The SC delay was further divided into diagnostic hospital delay and treatment delay, each with a median length of 16 days (range, 0-237) and 29 days (range, 0-73), respectively. Furthermore, we found that p16 status did not associate with delays. A longer patient delay associated with specific tumor factors, such as a larger primary tumor and a lower UICC 7th edition stage. Patients that had multiple visits or did not have a follow-up visit scheduled at the initial appointment had longer PHC delays. Treatment delay was significantly longer for patients scheduled for (chemo-)radiotherapy than for those undergoing surgery with or without (chemo-)radiotherapy.
Conclusions: Although delays remained short for the majority of OPSCC patients, long delays require further evaluation and improvement of management. Awareness of presenting symptoms among cancer risk patients and prompt referral practice or a follow-up visit at PHC represent key factors to shortening these delays. Ultimately, the causes for delays in SC appear multifactorial and require institutional quality control.
Keywords: Diagnostic delay; Human papillomavirus; Oropharyngeal cancer; Patient delay; Primary health care; Treatment delay.
Conflict of interest statement
The authors MN, TA, LB, AM, LJ, and KA declare that they have no competing interests.
Figures
Similar articles
-
Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.Laryngoscope. 2023 Jun;133(6):1394-1401. doi: 10.1002/lary.30307. Epub 2022 Jul 19. Laryngoscope. 2023. PMID: 35851669
-
Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.Am J Otolaryngol. 2019 Sep-Oct;40(5):626-630. doi: 10.1016/j.amjoto.2019.05.004. Epub 2019 May 14. Am J Otolaryngol. 2019. PMID: 31174931
-
Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.Cancer. 2016 Feb 15;122(4):634-41. doi: 10.1002/cncr.29782. Epub 2015 Nov 13. Cancer. 2016. PMID: 26565997
-
Advances in Diagnosis and Multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: State of the Art.Radiographics. 2019 Nov-Dec;39(7):2055-2068. doi: 10.1148/rg.2019190007. Epub 2019 Oct 11. Radiographics. 2019. PMID: 31603733 Review.
-
From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.Cancer Treat Rev. 2016 Jan;42:24-9. doi: 10.1016/j.ctrv.2015.10.009. Epub 2015 Oct 31. Cancer Treat Rev. 2016. PMID: 26547133 Review.
Cited by
-
Association Between Antibiotic Prescribing and Time to Diagnosis of Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg. 2023 Oct 1;149(10):919-928. doi: 10.1001/jamaoto.2023.2423. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37615970
-
Oral Cancer Disparities in the Outer US-affiliated Pacific Islands.Laryngoscope. 2023 Aug;133(8):1899-1905. doi: 10.1002/lary.30419. Epub 2022 Sep 27. Laryngoscope. 2023. PMID: 36165583 Free PMC article.
-
The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis.Front Public Health. 2022 Feb 21;10:809283. doi: 10.3389/fpubh.2022.809283. eCollection 2022. Front Public Health. 2022. PMID: 35265573 Free PMC article.
-
Patient Interval and Associated Factors in the Diagnostic Journey of Oral Cancer: A Hospital-Based Cross-Sectional Study from Kerala, India.Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3143-3149. doi: 10.31557/APJCP.2021.22.10.3143. Asian Pac J Cancer Prev. 2021. PMID: 34710990 Free PMC article.
References
-
- Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747–755. doi: 10.1002/hed.22015. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
